Prostate cancer: Scientists reveal new way to target stubborn cells

A new compound that targets hard-to-treat prostate cancer cells may pave the way for a new, more successful treatment in the future, a new study reports.
two researchers in lab

Researchers find a new compound that is more able to target stubborn prostate cancer cells.

The study, which is now published in Nature Communications, notes that this particular compound targets areas that lead to the multiplication of prostate cancer cells.

The researchers, at the New York University (NYU) School of Medicine in New York City, created a compound called cyclic peptoids.

Cyclic peptoids specifically seek targets that current prostate cancer treatments cannot.

The scientists were able to develop a compound that reduced prostate cancer cell growth (in cultures) by 95 percent, when compared with untreated cells.

How the treatment differs from current drugs

Current prostate cancer treatments target hormonal signals that encourage the growth of prostate cancer. People who take these type of medications, known as anti-androgen drugs, often experience a recurrence of cancer growth within months.

This has led to more research in hopes of developing new treatments that can work with these “undruggable” targets.

Gladys Benson

Gladys Benson

A young entrepreneur, a feminist and an enthusiastic person. Follow us on Twitter @gladysblog, on instagram @gladysbensonblog, on Facebook @ Or call 08098625131 for advert and booking

Leave a Reply

Your email address will not be published. Required fields are marked *